Amgen’s new cancer drug, Lumakras, achieved “significantly superior” results compared to the chemotherapy docetaxel in a phase 3 study.
Read the full post on Becker's Hospital Review - Healthcare News
Amgen cancer drug outperforms chemotherapy in study
